MICROGESTIN
Drug
Mayne Pharma Inc.
Total Payments
$11,775
Transactions
1
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $11,775 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,775 | 1 | 100.0% |
Top Doctors Receiving Payments for MICROGESTIN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Plymouth, NC | $11,775 | 1 |
Ad
Manufacturing Companies
- Mayne Pharma Inc. $11,775
Product Information
- Type Drug
- Total Payments $11,775
- Total Doctors 1
- Transactions 1
About MICROGESTIN
MICROGESTIN is a drug associated with $11,775 in payments to 1 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Mayne Pharma Inc..
Payment data is available from 2017 to 2017. In 2017, $11,775 was paid across 1 transactions to 1 doctors.
The most common payment nature for MICROGESTIN is "Consulting Fee" ($11,775, 100.0% of total).